Trump Issues Draft Guidance for Third Cycle of Drug Price Talks

The Trump administration issued a draft guidance that seeks to improve the transparency of the US government’s drug price negotiation program, continuing the Biden-era plan as it prepares for the third cycle of talks.

The 221-page guidance published Monday by the Centers for Medicare & Medicaid Services focuses on the implementation of the third round of the drug price negotiation program, a plan created under former President Joe Biden that gives the US powerful authority to negotiate drug costs for some of the most widely used and expensive drugs covered under Medicare.

The agency said it will announce up to ...